GENPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Genpharmasec Ltd reported sales of ₹85.66 Cr, operating profit of ₹1.64 Cr (OPM 1.91%) and net profit of ₹1.03 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
GENPHARMA quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
8.48
14.01
12.04
32.64
39.83
55.43
49.71
85.66
YoY Sales growth
32.92
37.35
131.54
441.29
369.69
295.65
312.87
162.44
Expenses
7.76
15.01
11.1
33.1
41.07
53.44
48.75
84.02
Operating Profit
0.72
-1
0.94
-0.46
-1.24
1.99
0.96
1.64
OPM
8.49%
-7.14%
7.81%
-1.41%
-3.11%
3.59%
1.93%
1.91%
Other Income
0.81
0.94
0.69
0.46
0.98
1.02
0.37
1.06
Interest
0.16
0.11
0.12
0.23
0.41
0.48
0.4
0.44
Depreciation
0.1
0.26
0.27
0.56
0.67
0.68
0.67
0.68
Profit before tax
1.27
-0.43
1.24
-0.79
-1.34
1.85
0.26
1.58
Tax
40.16%
-37.21%
2.42%
48.1%
-37.31%
27.03%
165.38%
34.81%
Net Profit
0.76
-0.27
1.22
-1.18
-0.83
1.36
-0.17
1.03
EPS in Rs
0.01
0
0.02
-0.02
-0.01
0.03
0
0.02
GENPHARMA profit & loss, annual (₹ Cr)
Metric
tooltips
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
-
26
30
34
140
231
Sales growth
-
-
19
11
315
243
Expenses
-
25
30
33
139
227
Operating Profit
-
0
0
0
1
3
OPM
-
1%
0.1%
1.2%
0.9%
1.4%
Other Income
-
0
1
3
3
3
Interest
-
0
0
0
1
2
Depreciation
-
0
0
1
2
3
Profit before tax
-
0
0
2
1
2
Tax
-
-300%
168%
29%
42%
-
Net Profit
-
1
0
2
1
1
EPS in Rs
-
0.02
0
0.03
0.03
0.04
Dividend Payout
-
0%
0%
0%
0%
-
GENPHARMA balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
55
55
55.37
55
55
Reserves
9
10
10.31
11
12
Borrowings
4
5
11.01
35
24
Other Liabilities
3
9
47.31
37
43
Total Liabilities
71
80
124
138
134
Fixed Assets
1
8
42.2
41
34
CWIP
0
0
0
0
0
Investments
19
20
2.05
2
1
Other Assets
51
53
79.75
95
99
Total Assets
71
80
124
138
134
GENPHARMA cash flows (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-3
-3
3
-18
Cash from Investing Activity
0
-28
-4
13
Cash from Financing Activity
3
48
-1
4
Net Cash Flow
0
17
-3
0
Free Cash Flow
-3
-3
-3
-18
CFO/OP
-1,277%
-7,275%
3,825%
-1,357%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit